The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival and toxicity outcomes in patients age 40 or older with relapsed metastatic germ cell tumors (mGCT) treated with high-dose chemotherapy (HDCT) and autologous peripheral-blood stem cell transplant (PBSCT).
 
Nabil Adra
Research Funding - Merck (Inst)
 
Costantine Albany
No Relationships to Disclose
 
Rafat Abonour
No Relationships to Disclose
 
Mohammad Issam Abu Zaid
No Relationships to Disclose
 
Dannillo Pereira
No Relationships to Disclose
 
Sandra K. Althouse
No Relationships to Disclose
 
Cheryl K Sullivan
No Relationships to Disclose
 
Nasser H. Hanna
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen; Celgene
Consulting or Advisory Role - Celgene